AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glybovin 1.25mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Glibenclamide (1.25mg)

Overview Glybovin 1.25mg Tablet

Diabetol 1.25mg tablets are indicated for managing type 2 diabetes in adults. A sulfonylurea, Diabetol helps regulate blood glucose, mitigating diabetes-related complications such as visual impairment and renal dysfunction. This medication can be prescribed alone or in conjunction with other therapies and should be taken with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and increase the risk of nerve damage, vision loss, kidney failure, and limb complications. Diabetol is part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management, as directed by your doctor. Lifestyle modifications are essential for diabetes control. Common side effects include nausea, headache, and vertigo. Hypoglycemia (low blood sugar) is also possible; recognize its symptoms (sweating, dizziness, headache, trembling) and know how to counteract it with rapid-acting glucose sources (e.g., fruit juice, candy). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart, thyroid, or hormonal disorders should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring is necessary, along with potential blood tests to evaluate blood cell counts and liver function.

Uses of Glybovin 1.25mg Tablet

Managing type 2 diabetes

Major Benefits of Glybovin 1.25mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It is recommended to take Glybovin 1.25mg Tablet with a meal.

Common Side effects of Glybovin 1.25mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Headache
  • Dizziness

How to use Glybovin 1.25mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take the Glybovin 1.25mg Tablet with a meal.

How Glybovin 1.25mg Tablet works:

Diabetic patients may use the antihyperglycemic agent, Glybovin 1.25mg tablets, which stimulate pancreatic insulin secretion to reduce blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glybovin 1.25mg tablets is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Glybovin 1.25mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human clinical trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Glybovin 1.25mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, it's recommended to track the nursing infant's blood glucose levels while the mother takes Glybovin 1.25mg tablets.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glybovin 1.25mg Tablets due to potential safety concerns. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glybovin 1.25mg tablets, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid Glybovin 1.25mg tablets due to the risk of severe hypoglycemia. Medical advice is recommended.

What if you forget to take Glybovin 1.25mg Tablet :

Omit a Glybovin 1.25mg Tablet if a meal is missed; conversely, administer an additional dose if an unplanned meal is consumed.

Facts to Know About Glybovin 1.25mg Tablet

LabelValue
Type of Compound Improved sulfonylurea medication
Potential for Dependence None.
Type of Treatment Medication for diabetes
Mechanism of Action Sulfonylurea agents (insulin stimulators)

FAQs on Glybovin 1.25mg Tablet

Glybovin 1.25mg tablets and Glipizide are distinct medications, yet both are sulfonylurea drugs prescribed for adult type 2 diabetes management.
Glybovin 1.25mg tablets are not indicated for polycystic ovary syndrome (PCOS) treatment, and supporting clinical data are absent.
Exercise extreme care when administering 1.25mg Glybovin tablets to the elderly, as this population exhibits increased vulnerability to hypoglycemia.
Glybovin 1.25mg tablets are unsuitable for treating prediabetes. While research exists, the available clinical data does not sufficiently support its efficacy in managing blood glucose levels that are elevated but below the diagnostic threshold for diabetes.
Glybovin 1.25mg tablets and Teneligliptin are both effective antidiabetic medications that manage blood glucose. Their mechanisms of action differ, resulting in varying adverse effects. Common side effects of Glybovin 1.25mg tablets include hypoglycemia and weight increase, whereas Teneligliptin is frequently associated with headache and nasopharyngitis. Importantly, Teneligliptin can induce hypoglycemia when co-administered with insulin or sulfonylureas, but it does not typically lead to weight gain.
Omitting your Glybovin 1.25mg Tablet is inadvisable, as it may negatively impact your diabetes management. Should you inadvertently miss a dose, administer it immediately upon recollection.
Glybovin 1.25mg Tablets are contraindicated in patients with known hypersensitivity to sulfonylureas, sulfonamides, or any other component of this medication.
Glybovin 1.25mg tablets may lead to weight increase. Therefore, maintaining a healthy diet and regular exercise are recommended during treatment. Skipping meals should be avoided to prevent hypoglycemia, which could result in excessive snacking or sugar consumption.
Combining Glybovin 1.25mg tablets with insulin aids in managing elevated blood glucose. This combination may reduce insulin requirements, but it also raises the chance of hypoglycemia. Dosage adjustments for both medications may be necessary, accompanied by consistent blood sugar monitoring. Consult your physician for clarification and adhere strictly to their prescribed regimen to optimize Glybovin 1.25mg tablet efficacy.
Concurrent use of Glybovin 1.25mg tablets and liraglutide is permissible, potentially enhancing glycemic control. Nevertheless, this combination elevates the hypoglycemia risk. Physician consultation is recommended, as dosage modification for either medication might be necessary.
Glybovin 1.25mg tablets are classified as sulfonylureas, not thiazolidinediones. While both drug classes treat diabetes, they represent distinct therapeutic categories.
Managing blood sugar during pregnancy often involves insulin therapy. Insulin injections are the typical treatment for gestational diabetes. Glybovin 1.25mg tablets may be recommended as a supplementary or alternative treatment option for gestational diabetes. Consult a physician before beginning Glybovin 1.25mg tablets.
Glybovin 1.25mg tablets are not associated with hair loss. Nevertheless, diabetes is a known cause of hair shedding. Consult your physician if you experience significant hair loss, as this may indicate another health problem or a deterioration of your diabetes.
Concurrent use of Glybovin 1.25mg tablets and pioglitazone is considered safe for individuals with diabetes. This combination therapy effectively manages blood glucose, reduces lipid levels in the blood, and improves blood pressure. Nevertheless, a heightened risk of hypoglycemia exists, potentially requiring dosage modifications.
Glybovin 1.25mg Tablet
4
MRP 5
25% off